Charting clonal heterogeneity in breast cancers : from bulk tumor genomes to single-cell genotypes

Traditional classifications and treatment of human cancers have operated with limitations surrounding tumor homogeneity and mutational stasis. Clinical metrics of malignant tumors focused on descriptive and behavioral properties such as tissue of origin, cellular morphologic features and extent of s...

Full description

Bibliographic Details
Main Author: Khattra, Jaswinder
Language:English
Published: University of British Columbia 2015
Online Access:http://hdl.handle.net/2429/53485
id ndltd-UBC-oai-circle.library.ubc.ca-2429-53485
record_format oai_dc
spelling ndltd-UBC-oai-circle.library.ubc.ca-2429-534852018-01-05T17:28:13Z Charting clonal heterogeneity in breast cancers : from bulk tumor genomes to single-cell genotypes Khattra, Jaswinder Traditional classifications and treatment of human cancers have operated with limitations surrounding tumor homogeneity and mutational stasis. Clinical metrics of malignant tumors focused on descriptive and behavioral properties such as tissue of origin, cellular morphologic features and extent of spread. Missing has been an understanding of the dynamics of cellular subpopulations that underpin divergent functional properties in space and time. This dissertation is focused on the development and application of methods, including next generation DNA sequencing, computational modeling, and single-cell genotyping protocols to elucidate breast tumor heterogeneity and clonal evolution at single nucleotide and single-cell resolution. First, I present advances in our knowledge of the mutational spectrum that may occur and evolve in an individual epithelial cancer, namely a lobular breast cancer metastases and matched primary tumor separated by a nine year interval. This seminal study demonstrated clonal evolution in a patient’s breast cancer and the successful application of targeted deep sequencing for determining digital allelic prevalences and clonal genotypes in bulk tumors. Second, I describe the diversity of genomic sequence and clonal heterogeneity in tumors of the triple-negative breast cancer subtype. The study uncovered wide clonal diversity in these primary tumors at first diagnosis. Third, I demonstrate via genotyping single tumor cells, that computational inferences of tumor clonal architecture can be made reliably from bulk tissue-derived data sets. This was performed using both somatic point mutations and loss of heterozygosity loci as clonal marks. And fourth, I applied single-cell analysis to study the clonal evolution in breast tumor murine xenografts following engraftment and serial passaging. This research uncovered a range of outcomes in tumor clonal composition upon initial engraftment and serial passaging. The same clonal groups were found to arise independently in separate xenografts derived from the same primary tumor, suggesting selection of functionally significant genotypes. Comprehensive capabilities in the measurement and analysis of clonal structure in cancers offers improved classification and combinatorial treatments of subpopulations in heterogeneous tumors and better use of murine xenograft models. Functionally relevant subpopulations of tumor cells, irrespective of numerical abundance or spatiotemporal persistence, can thereby be targeted using clonally informative genomic profiles. Medicine, Faculty of Pathology and Laboratory Medicine, Department of Graduate 2015-05-26T16:27:03Z 2015-05-26T16:27:03Z 2015 2015-09 Text Thesis/Dissertation http://hdl.handle.net/2429/53485 eng Attribution-NonCommercial-NoDerivs 2.5 Canada http://creativecommons.org/licenses/by-nc-nd/2.5/ca/ University of British Columbia
collection NDLTD
language English
sources NDLTD
description Traditional classifications and treatment of human cancers have operated with limitations surrounding tumor homogeneity and mutational stasis. Clinical metrics of malignant tumors focused on descriptive and behavioral properties such as tissue of origin, cellular morphologic features and extent of spread. Missing has been an understanding of the dynamics of cellular subpopulations that underpin divergent functional properties in space and time. This dissertation is focused on the development and application of methods, including next generation DNA sequencing, computational modeling, and single-cell genotyping protocols to elucidate breast tumor heterogeneity and clonal evolution at single nucleotide and single-cell resolution. First, I present advances in our knowledge of the mutational spectrum that may occur and evolve in an individual epithelial cancer, namely a lobular breast cancer metastases and matched primary tumor separated by a nine year interval. This seminal study demonstrated clonal evolution in a patient’s breast cancer and the successful application of targeted deep sequencing for determining digital allelic prevalences and clonal genotypes in bulk tumors. Second, I describe the diversity of genomic sequence and clonal heterogeneity in tumors of the triple-negative breast cancer subtype. The study uncovered wide clonal diversity in these primary tumors at first diagnosis. Third, I demonstrate via genotyping single tumor cells, that computational inferences of tumor clonal architecture can be made reliably from bulk tissue-derived data sets. This was performed using both somatic point mutations and loss of heterozygosity loci as clonal marks. And fourth, I applied single-cell analysis to study the clonal evolution in breast tumor murine xenografts following engraftment and serial passaging. This research uncovered a range of outcomes in tumor clonal composition upon initial engraftment and serial passaging. The same clonal groups were found to arise independently in separate xenografts derived from the same primary tumor, suggesting selection of functionally significant genotypes. Comprehensive capabilities in the measurement and analysis of clonal structure in cancers offers improved classification and combinatorial treatments of subpopulations in heterogeneous tumors and better use of murine xenograft models. Functionally relevant subpopulations of tumor cells, irrespective of numerical abundance or spatiotemporal persistence, can thereby be targeted using clonally informative genomic profiles. === Medicine, Faculty of === Pathology and Laboratory Medicine, Department of === Graduate
author Khattra, Jaswinder
spellingShingle Khattra, Jaswinder
Charting clonal heterogeneity in breast cancers : from bulk tumor genomes to single-cell genotypes
author_facet Khattra, Jaswinder
author_sort Khattra, Jaswinder
title Charting clonal heterogeneity in breast cancers : from bulk tumor genomes to single-cell genotypes
title_short Charting clonal heterogeneity in breast cancers : from bulk tumor genomes to single-cell genotypes
title_full Charting clonal heterogeneity in breast cancers : from bulk tumor genomes to single-cell genotypes
title_fullStr Charting clonal heterogeneity in breast cancers : from bulk tumor genomes to single-cell genotypes
title_full_unstemmed Charting clonal heterogeneity in breast cancers : from bulk tumor genomes to single-cell genotypes
title_sort charting clonal heterogeneity in breast cancers : from bulk tumor genomes to single-cell genotypes
publisher University of British Columbia
publishDate 2015
url http://hdl.handle.net/2429/53485
work_keys_str_mv AT khattrajaswinder chartingclonalheterogeneityinbreastcancersfrombulktumorgenomestosinglecellgenotypes
_version_ 1718584760368889856